However, we could not rule out that other synergistic regulatory pathways (e.g., RNA-binding proteins35, transcription factors or epigenetic alterations36) are also influenced by hypercholesterolemia also contributing to the downregulation of Adrb2. The gene discussed is ADRB2; the disease is Hypercholesterolemia.